Jon Ritter

Medicine & Life Sciences

1. Lung 100%
2. Allografts 61%
3. Lung Transplantation 46%
4. Neoplasms 43%
5. Transplants 36%
6. Carcinoma 29%
7. Transforming Growth Factors 29%
8. Neuroendocrine Carcinoma 23%
9. Skin 21%
10. Loss of Heterozygosity 20%
11. Reperfusion Injury 19%
12. Interleukin-10 19%
13. T-Lymphocytes 18%
14. Carcinoma, Intraductal, Noninfiltrating 18%
15. Differential Diagnosis 18%
16. Lymphoma 17%
17. Bronchi 16%
18. Biopsy 16%
19. Immunohistochemistry 15%
20. Nitric Oxide Synthase Type II 15%
21. Breast 15%
22. Paraffin 15%
23. Genes 14%
24. Emphysema 14%
25. Plasma Cell Granuloma 14%
26. Graft Rejection 14%
27. Skin Neoplasms 14%
28. Transfection 13%
29. Adenoviridae 13%
30. Hyperplasia 12%
31. Breast Neoplasms 12%
32. Myeloid Sarcoma 12%
33. Idiopathic Pulmonary Fibrosis 12%
34. Transplantation 12%
35. Adenocarcinoma 12%
36. Medullary Carcinoma 12%
37. Lymphoid Tissue 11%
38. Non-Small Cell Lung Carcinoma 11%
39. Pleura 11%
40. Large Cell Carcinoma 11%
41. Liver 11%
42. Histocompatibility Antigens Class II 10%
43. Pneumonia 10%
44. Melanoma 10%
45. Inbred F344 Rats 10%
46. Hamartoma 10%
47. Lung Neoplasms 10%
48. Carcinoid Tumor 10%
49. Respiratory System 10%
50. Tomography 9%